Back to Search
WILLIAM CALHOUN, MD
MD
Cardiovascular Disease Physician
NPI: 1932219177IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
14856(MS)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN SHREVEPORT
Class of 1989
Research & Publications (20)
Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone.
PMID 11549529·Am J Respir Crit Care Med·2001
3-trial
The effect of salmeterol on markers of airway inflammation following segmental allergen challenge.
PMID 11282760·Am J Respir Crit Care Med·2001
3-trial
Predicting worsening asthma control following the common cold.
PMID 18768579·Eur Respir J·2008
4-observational
Alterations of the arginine metabolome in asthma.
PMID 18635886·Am J Respir Crit Care Med·2008
8-other
Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma.
PMID 18583575·Am J Respir Crit Care Med·2008
8-other
Non-invasive measurements of exhaled NO and CO associated with methacholine responses in mice.
PMID 18505586·Respir Res·2008
7-preclinical
Effect of nebulized arformoterol on airway function in COPD: results from two randomized trials.
PMID 18259972·COPD·2008
3-trial
Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines.
PMID 18206505·J Allergy Clin Immunol·2008
8-other
Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation.
PMID 17991792·J Appl Physiol (1985)·2008
3-trial
The safety and efficacy of zileuton controlled-release tablets as adjunctive therapy to usual care in the treatment of moderate persistent asthma: a 6-month randomized controlled study.
PMID 17530530·J Asthma·2007
3-trial
Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
PMID 17472819·Clin Ther·2007
4-observational
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.
PMID 17291857·J Allergy Clin Immunol·2007
8-other
IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expression.
PMID 17170387·Am J Respir Crit Care Med·2007
8-other
(R)-albuterol for asthma: pro [a.k.a. (S)-albuterol for asthma: con].
PMID 17060667·Am J Respir Crit Care Med·2006
7-preclinical
In vitro cytotoxicity of Manville Code 100 glass fibers: effect of fiber length on human alveolar macrophages.
PMID 16569233·Part Fibre Toxicol·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 2892 S LAMAR BLVD
OXFORD, MS 38655 - Phone
- (662) 234-7441
Quick Facts
- NPI
- 1932219177
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 3
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile